104 related articles for article (PubMed ID: 31255902)
21. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice.
Haston CK; Wang M; Dejournett RE; Zhou X; Ni D; Gu X; King TM; Weil MM; Newman RA; Amos CI; Travis EL
Hum Mol Genet; 2002 Aug; 11(16):1855-63. PubMed ID: 12140188
[TBL] [Abstract][Full Text] [Related]
22. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
Filderman AE; Genovese LA; Lazo JS
Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
[TBL] [Abstract][Full Text] [Related]
23. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
Baecher-Allan CM; Barth RK
Reg Immunol; 1993; 5(3-4):207-17. PubMed ID: 7694632
[TBL] [Abstract][Full Text] [Related]
24. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma.
Falay O; Öztürk E; Bölükbaşı Y; Gümüş T; Örnek S; Özbalak M; Çetiner M; Demirkol O; Ferhanoğlu B
Leuk Lymphoma; 2017 May; 58(5):1114-1122. PubMed ID: 28185527
[TBL] [Abstract][Full Text] [Related]
25. Atopy and risk of non-Hodgkin lymphoma.
Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schöllkopf C; Sundström C; Chang ET; Koskela P; Adami HO; Hjalgrim H
J Natl Cancer Inst; 2007 Jan; 99(2):158-66. PubMed ID: 17227999
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
27. Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients.
Nuver J; Lutke Holzik MF; van Zweeden M; Hoekstra HJ; Meijer C; Suurmeijer AJ; Groen HJ; Hofstra RM; Sluiter WJ; Groen H; Sleijfer DT; Gietema JA
Pharmacogenet Genomics; 2005 Jun; 15(6):399-405. PubMed ID: 15900213
[TBL] [Abstract][Full Text] [Related]
28. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance.
Schwartz DR; Homanics GE; Hoyt DG; Klein E; Abernethy J; Lazo JS
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4680-5. PubMed ID: 10200322
[TBL] [Abstract][Full Text] [Related]
29. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
30. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
31. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
Stamatoullas A; Brice P; Bouabdallah R; Mareschal S; Camus V; Rahal I; Franchi P; Lanic H; Tilly H
Br J Haematol; 2015 Jul; 170(2):179-84. PubMed ID: 25891777
[TBL] [Abstract][Full Text] [Related]
32. Acute bleomycin toxicity.
Ganick DJ; Peters ME; Hafez GR
Am J Pediatr Hematol Oncol; 1980; 2(3):249-52. PubMed ID: 6159802
[TBL] [Abstract][Full Text] [Related]
33. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
Lazo JS; Humphreys CJ
Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
[TBL] [Abstract][Full Text] [Related]
34. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
[TBL] [Abstract][Full Text] [Related]
35. Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels.
Kseibati MO; Shehatou GSG; Sharawy MH; Eladl AE; Salem HA
Life Sci; 2020 Apr; 246():117423. PubMed ID: 32057902
[TBL] [Abstract][Full Text] [Related]
36. Epithelial cell-derived transforming growth factor-beta in bleomycin-induced pulmonary injury.
Kumar RK; O'Grady R; Maronese SE; Wilson MR
Int J Exp Pathol; 1996 Jun; 77(3):99-107. PubMed ID: 8774378
[TBL] [Abstract][Full Text] [Related]
37. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
38. A case of bleomycin-induced lung toxicity.
Tetikkurt C; Ongel D; Tetikkurt S
Monaldi Arch Chest Dis; 2018 Nov; 88(3):981. PubMed ID: 30398042
[TBL] [Abstract][Full Text] [Related]
39. Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response.
Iacovino JR; Leitner J; Abbas AK; Lokich JJ; Snider GL
JAMA; 1976 Mar; 235(12):1253-5. PubMed ID: 55505
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors.
Avivi I; Hardak E; Shaham B; Igla M; Rowe JM; Dann EJ
Ann Hematol; 2012 Feb; 91(2):215-21. PubMed ID: 21603918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
